-
公开(公告)号:EP1562956A2
公开(公告)日:2005-08-17
申请号:EP03789996.0
申请日:2003-11-21
申请人: Tularik Inc. , Japan Tobacco, Inc.
发明人: FOX, Brian, M. , FURUKAWA, N.,Japan Tobacco, Inc. , HAO, Xiaolin , IIO, K.,Japan Tobacco, Inc. , INABA, T.,Japan Tobacco, Inc. , JACKSON, Simon, M. , KAYSER, Frank , LABELLE, Marc , LI, Kexue , MATSUI, T.,Japan Tobacco, Inc. , MCMINN, Dustin, L. , OGAWA, N.,Japan Tobacco, Inc. , RUBENSTEIN, Steven, M. , SAGAWA, S.,Japan Tobacco, Inc. , SUGIMOTO, K.,Japan Tobacco, Inc. , SUZUKI, M.,Japan Tobacco, Inc. , TANAKA, M.,Japan Tobacco, Inc. , YE, Guosen , YOSHIDA, A.,Japan Tobacco, Inc. , ZHANG, Jian
IPC分类号: C07D491/052
CPC分类号: C07D491/04
摘要: Compounds, pharmaceutical compositions and methods that are useful in the treatment or prevention of metabolic and cell proliferative diseases or conditions are provided herein. In particular, the invention provides compounds which modulate the activity of proteins involved in lipid metabolism and cell proliferation.